Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Calithera Biosciences, Inc. (CALA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| TAKEDA PHARMACEUTICAL CO LTD (Former 10% Owner) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Disposed of 1,000,000 convertible preferred
@ $0 |
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| Sjogren Eric (SR. VP, DRUG DISCOVERY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 279 shares
@ $0.4461, valued at
$124.5 |
|
| 01/25/2023 |
4
| Kuriakose Emil (CHIEF MEDICAL OFFICER) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 79 shares
@ $0.4461, valued at
$35.2 |
|
| 01/25/2023 |
4
| Molineaux Susan (PRESIDENT & CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 526 shares
@ $0.4461, valued at
$234.6 |
|
| 01/25/2023 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 317 shares
@ $0.4461, valued at
$141.4 |
|
| 01/25/2023 |
4
| Molineaux Christopher (SR. VP, DEVELOPMENT) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 217 shares
@ $0.4461, valued at
$96.8 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| JONES SUZY (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.2, valued at
$4k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Garland J. Scott (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.2, valued at
$4k
|
|
| 06/03/2022 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.2, valued at
$4k
|
|
| 06/03/2022 |
4
| Wise Blake (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.2, valued at
$4k
|
|
| 06/03/2022 |
4
| Orford Keith (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.2, valued at
$4k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Molineaux Susan (PRESIDENT & CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 597,475 options to buy
@ $0.44, valued at
$262.9k
|
|
| 01/27/2022 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 215,000 options to buy
@ $0.44, valued at
$94.6k
|
|
| 01/27/2022 |
4
| Ray Sumita (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 165,000 options to buy
@ $0.44, valued at
$72.6k
|
|
| 01/27/2022 |
4
| Sjogren Eric (SR. VP, DRUG DISCOVERY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 165,000 options to buy
@ $0.44, valued at
$72.6k
|
|
| 01/27/2022 |
4
| Parlati Francesco (SR. VP, RESEARCH) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 165,000 options to buy
@ $0.44, valued at
$72.6k
|
|
| 01/27/2022 |
4
| Molineaux Christopher (SR. VP, DEVELOPMENT) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 165,000 options to buy
@ $0.44, valued at
$72.6k
|
|
| 01/27/2022 |
4
| Orford Keith (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.44, valued at
$17.6k
|
|
| 01/27/2022 |
4
| Kuriakose Emil (CHIEF MEDICAL OFFICER) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 215,000 options to buy
@ $0.44, valued at
$94.6k
|
|
| 01/25/2022 |
4
| Parlati Francesco (SR. VP, RESEARCH) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 4,794 shares
@ $0.4915, valued at
$2.4k
|
|
| 01/25/2022 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 5,586 shares
@ $0.4915, valued at
$2.7k
|
|
| 01/25/2022 |
4
| Sjogren Eric (SR. VP, DRUG DISCOVERY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 4,794 shares
@ $0.4915, valued at
$2.4k
|
|
| 01/25/2022 |
4
| Kuriakose Emil (CHIEF MEDICAL OFFICER) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 666 shares
@ $0.4915, valued at
$327.3 |
|
| 01/06/2022 |
4
| Parlati Francesco (SR. VP, RESEARCH) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 18,077 shares
@ $0.6604, valued at
$11.9k
|
|
| 01/06/2022 |
4
| Kuriakose Emil (CHIEF MEDICAL OFFICER) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,855 shares
@ $0.6604, valued at
$2.5k
|
|
| 01/06/2022 |
4
| Sjogren Eric (SR. VP, DRUG DISCOVERY) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 18,077 shares
@ $0.6604, valued at
$11.9k
|
|
| 01/06/2022 |
4
| Wong Stephanie (See Remarks) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 18,077 shares
@ $0.6604, valued at
$11.9k
|
|
| 11/12/2021 |
4
| Orford Keith (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Sold 30,000 shares
@ $0.8565, valued at
$25.7k
Sold 48,190 shares
@ $0.88, valued at
$42.4k
|
|
| 11/10/2021 |
4
| Molineaux Susan (PRESIDENT & CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Bought 100,000 shares
@ $0.8467, valued at
$84.7k
|
|
| 11/10/2021 |
4
| DRACHMAN JONATHAN G (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Bought 200,000 shares
@ $0.8595, valued at
$171.9k
|
|
|
|
|